medigraphic.com
SPANISH

Salud Jalisco

ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 3

<< Back Next >>

Sal Jal 2022; 9 (3)

Adenocarcinoma de células claras de vagina en paciente de 14 años

Sandoval-Flores I, López-Ramírez P, Pratts-Suárez A, Figueroa-Sandoval JF
Full text How to cite this article

Language: Spanish
References: 14
Page: 196-199
PDF size: 325.69 Kb.


Key words:

Adenocarcinoma of the vagina, surgery, chemotherapy, radiotherapy.

ABSTRACT

Introduction: Adenocarcinoma of the vagina is a rare tumor in girls. The report of the first case of this disease in the Mexican Republic is presented.
Female of 14 years of age, with no history of exposure to diesterol (DES). The clinical picture begins at age 12 with leucorrhoea and vaginal bleeding. She goes with a doctor who performs biopsy and is diagnosed as vaginal adenocarcinoma. It is subject to posterior excenteration and the performance of neovagina with myocutaneous flap of rectus abdominis muscle. The report with clear cell adenocarcinoma report of vagina with extension to cervix and 4 positive nodes of 7 of left side and 1 of two of right side. She is indicated for treatment with external radiotherapy with linear accelerator, technique in spade a dose of 5,000 cGy in 25 sessions, with concomitance of two cycles of Cisplatino beginning May 27 and ended on 07-07-2016 with data of proctitis and Grade II cystitis, weight loss of 8 kg and grade II radiodermitis. No data on tumor activity in the last clinical review. We discuss the management strategies, as well as the quality of life of these patient.


REFERENCES

  1. Williams R R, Scheuntzer R. J Clear cell adenocarcinoma of thevagina in a girl whose had taken dhietylstillbestrol. . Calif Med1973;118 :53-55.

  2. Herbst, AL Clear cell adenocarcinoma and the current status ofDES exposed females. Cancer 1981; 48:484-488.

  3. American Cancer Society, ¿Cuáles son los factores de riesgopara el cáncer de vagina?, American Cancer Society 2014

  4. Herbst AL, Robboy S J, Scully R E et al. Clear cell adenocarcinomaof the vagina and cervix in girls Analisis of 170 registry cases.Am J Obstret Gynecol 1974 ;119:713-724.

  5. Mc Nall R Y, Nowicki, P D, Miller B, et al. Adenocarcinomaof the cervix and vagina pediatric patients . Pediatrics BloodCancer 2004 ;43: 289-294.

  6. Herbst AL, Scully RE. Adenocarcinoma of the vagina inadolescence. A report of 7 cases including 6 clear-cellcarcinomas. Cancer 1970;25: 745-750.

  7. Herbst AL,Felder H, Pozkanzer DC. Adenocarcinoma devagina. Th e New England Journal of Medicine 1971; 284: 878-

  8. 881.8. FernandezPineda,I, Spunt ,S, Parida,L, Krasin,M, Davidoff ,A, Rao,B. Vaginaltumors in childhood: the experience of St Jude Children’sResearch Hospital. J.Pediat Surg 2011;46:2071-2075.

  9. Herbst,A,Ulferder,H, Poskanzer,D. Adenocarcinoma of the vagina-Association of maternal stilbestrol therapy with tumor appearancein Young women. N Engl J Med 1971;284:878-881.

  10. Hassan E,Creatsas G,Michalas S.Genital tumors during childhoodand adolescence: a clinical and pathologic study of 71 cases.ClinExp Obstet Gynecol.1999;26:20-21.

  11. Donnelly LF, Gylys-Morin VM, Warner BW, Hillard PJ. Casereport: clear cell adenocarcinoma of the vagina in a 5 year oldgirl:imaging fi ndings. Clin Radiol 1998;53:69-72.

  12. Huo D, Anderson D, Palmer JR, Herbst AL. Incidence rates andrisks of diethylstilbestrol related clear cell adenocarcinoma of thevagina and cervix. Update aft er 40 year follow-up. Gynecol Oncol2017;146:566-571.

  13. Adams TS, Cuello MA. Cancer of the vagina. Int J Gynaecol Obstet2018;143 Suppl 2:14-21.

  14. Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina:2021update. Int J Gynaecol Obstet 2021 Oct 155 Suppl 1:19-27.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Sal Jal. 2022;9